Tomocube Inc
Tomocube, Inc. engages in the manufacture and sale of optical devices and medical equipment. Its holotomography (HT) products include HT-X1 for live-cell imaging and analysis; and HT-2H for 3D live cell imaging. The company also offers TomoAnalysis, a 3D image visualization and analysis software. In addition, it provides accessories, such as HT-ready 96 well plates; TomoDish that is designed to a… Read more
Market Cap & Net Worth: Tomocube Inc (475960)
Tomocube Inc (KQ:475960) has a market capitalization of $482.48 Million (₩706.45 Billion) as of March 18, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #12955 globally and #331 in its home market, demonstrating a -2.20% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Tomocube Inc's stock price ₩53300.00 by its total outstanding shares 13254274 (13.25 Million).
Tomocube Inc Market Cap History: 2024 to 2026
Tomocube Inc's market capitalization history from 2024 to 2026. Data shows growth from $138.95 Million to $482.48 Million (0.00% CAGR).
Tomocube Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Tomocube Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.02x
Tomocube Inc's market cap is 0.02 times its annual revenue
1728.56x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2024 | $138.95 Million | $5.94 Billion | -$8.30 Billion | 0.02x | N/A |
Competitor Companies of 475960 by Market Capitalization
Companies near Tomocube Inc in the global market cap rankings as of March 18, 2026.
Key companies related to Tomocube Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Tomocube Inc Historical Marketcap From 2024 to 2026
Between 2024 and today, Tomocube Inc's market cap moved from $138.95 Million to $ 482.48 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩482.48 Million | +4.51% |
| 2025 | ₩461.66 Million | +232.25% |
| 2024 | ₩138.95 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Tomocube Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $482.48 Million USD |
| MoneyControl | $482.48 Million USD |
| MarketWatch | $482.48 Million USD |
| marketcap.company | $482.48 Million USD |
| Reuters | $482.48 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.